|
Combining HR from same study sub-groups for meta-analysis
|
|
0
|
61
|
November 28, 2023
|
|
Numerical Differences in Survival Probability Estimates between coxph and cph Functions
|
|
7
|
119
|
November 20, 2023
|
|
Immortal time bias
|
|
2
|
221
|
October 29, 2023
|
|
RMS Cox PH Model
|
|
31
|
944
|
October 7, 2023
|
|
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times
|
|
2
|
210
|
October 3, 2023
|
|
ROC has a S shape, why?
|
|
30
|
2625
|
August 25, 2023
|
|
Time-to-event analysis with a blocking factor
|
|
3
|
283
|
August 14, 2023
|
|
Survival analysis vs. nested case-control analysis
|
|
3
|
413
|
August 14, 2023
|
|
External validation or a bigger modelling sample?
|
|
9
|
492
|
August 12, 2023
|
|
RMS Case Study in Parametric Survival Modeling
|
|
0
|
11423
|
September 17, 2021
|
|
Survival curves - categorization vs continuous in cox model
|
|
5
|
470
|
August 11, 2023
|
|
Case-control study with and corresponding subgroup
|
|
2
|
333
|
July 20, 2023
|
|
Hazard ratio plots with non-linear & time-varying effects in R
|
|
29
|
35126
|
June 30, 2023
|
|
Calculating fraction of new information in Cox proportional hazard models
|
|
9
|
597
|
June 23, 2023
|
|
How to condunct a survival meta-analysis when the data for standard deviation ist missing?
|
|
1
|
310
|
June 3, 2023
|
|
Adjusting for sample size imbalance in a predictor variable in Cox PH model
|
|
2
|
594
|
May 30, 2023
|
|
Progression in cancer trials
|
|
20
|
2389
|
May 20, 2023
|
|
Treatment effect on survival in observational data with treatment times after diagnosis
|
|
4
|
419
|
May 16, 2023
|
|
Does including time to event or censoring in a logistic regression model cause collider bias?
|
|
3
|
634
|
May 3, 2023
|
|
HR really close to 1 but significant - how to interpret and report?
|
|
9
|
845
|
April 25, 2023
|
|
Removing survivorship bias in a survival model
|
|
2
|
709
|
April 13, 2023
|
|
Imbalance between incident cases and controls
|
|
5
|
702
|
April 11, 2023
|
|
What is the type of my study, case control or retrospective cohort?
|
|
6
|
804
|
January 27, 2023
|
|
Effectiveness of Paxlovid a retrospective study
|
|
5
|
754
|
January 11, 2023
|
|
Justification of sample size for the generation of a prediction model
|
|
7
|
1311
|
January 11, 2023
|
|
Should we account for competing risk when estimating incidence rate?
|
|
3
|
594
|
January 5, 2023
|
|
Precision-based sample size calculation for one survival curve
|
|
3
|
801
|
November 16, 2022
|
|
Conceptual question about survival analysis vs logistic regression: when is one more appropriate than the other?
|
|
16
|
12692
|
October 27, 2022
|
|
Background to PFS endpoint
|
|
19
|
6688
|
October 6, 2022
|
|
Method to obtain optimal cut-off point for survival outcomes
|
|
3
|
1735
|
October 1, 2022
|